Cancer treatment company plans for public offeringJuly 25, 2019PetCure Oncology has engaged Boustead Securities for a Regulation D 506(c) offering.
SPONSORED CONTENTSupporting their immune system healthHill’s Prescription Diet i/d is formulated with clinically proven antioxidants to support healthy immune systems for cats. + Learn More